title: Testicular cancer: maintaining the high cure rate.
abstract: The management of germ cell tumors has advanced dramatically, with cure rates approaching 90% to 95%. Treatment of stage I/A seminomas generally includes orchiectomy and adjuvant radiotherapy. Treatment of stage I/A nonseminomatous germ cell tumors involves orchiectomy followed by retroperitoneal lymph node dissection or active surveillance. One of the major advances has been the introduction of cisplatin-based chemotherapy for metastatic disease and the development of a system of risk attribution. The logical management of any patient with curable disease is to provide curative therapy and then follow the patient in a structured manner, to diagnose and treat any complications in a timely manner.
authors.affiliation: Division of Oncology, USC Norris Cancer Center, University of Southern California, Los Angeles, California, USA. draghava@hsc.usc.edu
authors.forename: Derek
authors.initials: D
authors.lastname: Raghavan
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D019468:Disease Management; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D012307:Risk Factors; D018239:Seminoma / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D013736:Testicular Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*
chemical_list: D002945:Cisplatin